SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-109945
Filing Date
2007-05-10
Accepted
2007-05-10 14:23:17
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 415971
2 SECOND AMENDMENT OF LEASE DATED AS OF MARCH 7, 2007 FROM BHX, LLC dex101.htm EX-10.1 13715
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER, SECTION 302 dex311.htm EX-31.1 10293
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER, SECTION 302 dex312.htm EX-31.2 10053
5 CERTIFICATION OF CEO AND CFO, SECTION 906 dex321.htm EX-32.1 4974
  Complete submission text file 0001193125-07-109945.txt   456421
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 07836814
SIC: 2836 Biological Products, (No Diagnostic Substances)